⌕
Insulet · PODD · Nasdaq
Tenet 61 · Solid
Compare
$145.34+0.03%At closeTenet 61 · Solid
$145.34+0.05 (+0.03%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Insulet (PODD) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is PODD's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Defense WorldNov 16, 2026 · 03:57 ET
Insulet Corporation $PODD Stock Position Boosted by Fifth Third Bancorp

Fifth Third Bancorp boosted its stake in Insulet Corporation (NASDAQ: PODD) by 21.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owne…

PODD 0.0% todayRead at source ↗
● Zacks Investment ResearchNov 12, 2026 · 10:46 ET
Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

PODD 0.0% todayRead at source ↗
● Zacks Investment ResearchNov 12, 2026 · 10:36 ET
Insulet (PODD) Just Overtook the 20-Day Moving Average

After reaching an important support level, Insulet (PODD) could be a good stock pick from a technical perspective. PODD surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.…

PODD 0.0% todayRead at source ↗
● Seeking AlphaNov 11, 2026 · 11:39 ET
Insulet: Rivals Are Building Patch Pumps, But Insulet Already Owns The Pharmacy Counter

Insulet is undervalued, trading at a sub-median multiple despite 20% revenue growth and expanding margins. PODD's pharmacy-based, fully disposable model and dominant new patient onboarding differentiate it from emerging …

PODD 0.0% todayRead at source ↗
● Zacks Investment ResearchNov 10, 2026 · 16:46 ET
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"

Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.…

PODD 0.0% todayRead at source ↗
● Business WireNov 9, 2026 · 07:00 ET
For World Diabetes Day, Insulet Launches “Give Yourself the Freedom to” Campaign, Encouraging People with Diabetes to Prioritize Their Well-Being

ACTON, Mass.--(BUSINESS WIRE)--In recognition of World Diabetes Day on November 14, 2026, Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipo…

PODD 0.0% todayRead at source ↗
● Defense WorldNov 8, 2026 · 04:45 ET
Insulet Corporation $PODD Shares Purchased by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC increased its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 48.8% in the third quarter, according to its most recent filing with the SEC. The fund owned 13,883 shares o…

PODD 0.0% todayRead at source ↗
● MarketBeatNov 4, 2026 · 14:15 ET
What Insulet (PODD) Said on Its Q3 Earnings Call

Insulet NASDAQ: PODD reported third-quarter revenue of $842 million, up 19.2% on a reported basis and 19.6% on a constant-currency basis, as international growth outpaced the company's plans and U.S. performance landed w…

PODD 0.0% todayRead at source ↗
● Seeking AlphaNov 4, 2026 · 13:14 ET
Insulet Corporation (PODD) Q3 2026 Earnings Call Transcript

Insulet Corporation (PODD) Q3 2026 Earnings Call Transcript…

PODD 0.0% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 10:31 ET
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street es…

PODD 0.0% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 09:11 ET
Insulet (PODD) Q3 Earnings and Revenues Surpass Estimates

Insulet (PODD) came out with quarterly earnings of $1.99 per share, beating the Zacks Consensus Estimate of $1.59 per share. This compares to earnings of $1.24 per share a year ago.…

PODD 0.0% todayRead at source ↗
● Business WireNov 4, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Insulet Reports Third Quarter 2026 Results

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results…

PODD 0.0% todayRead at source ↗
● Business WireNov 3, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Insulet to Participate in the 2026 Jefferies Global Healthcare Conference in London

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the 2026 Jeffe…

PODD 0.0% todayRead at source ↗
● Defense WorldNov 2, 2026 · 06:05 ET
Insulet Corporation $PODD Stock: International Assets Investment Management LLC Boosts Stake

International Assets Investment Management LLC grew its position in Insulet Corporation (NASDAQ: PODD) by 61,543.8% during a recent quarter, according to the company in its most recent disclosure with the Securities and …

PODD 0.0% todayRead at source ↗
● Zacks Investment ResearchOct 28, 2026 · 11:01 ET
Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth

Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

PODD 0.0% todayRead at source ↗
● GlobeNewsWireOct 26, 2026 · 08:32 ET
Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly

A single device designed to replace months to years of repeat injections, with potential applications well beyond its lead contraception program…

PODD 0.0% todayRead at source ↗
● Defense WorldOct 18, 2026 · 04:41 ET
Insulet Corporation $PODD Shares Sold by Curated Wealth Partners LLC

Curated Wealth Partners LLC lessened its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 83.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commiss…

PODD 0.0% todayRead at source ↗
● Zacks Investment ResearchOct 16, 2026 · 10:46 ET
Here's Why Insulet (PODD) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

PODD 0.0% todayRead at source ↗
● Business WireOct 12, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Insulet Announces Omnipod Discover Now Available in U.S.

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the U.S. full market release of Omnipod Discov…

PODD 0.0% todayRead at source ↗
● Business WireOct 1, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financ…

PODD 0.0% todayRead at source ↗
● Zacks Investment ResearchSep 25, 2026 · 10:45 ET
Why Insulet (PODD) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

PODD 0.0% todayRead at source ↗
● Defense WorldSep 25, 2026 · 04:02 ET
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum

Insulet (NASDAQ: PODD) Chief Operating Officer Eric Benjamin said the company remains focused on expanding adoption of automated insulin delivery, or AID, systems across large and underpenetrated diabetes markets, while …

PODD 0.0% todayRead at source ↗
● Seeking AlphaSep 24, 2026 · 17:09 ET
Insulet Corporation (PODD) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript

Insulet Corporation (PODD) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript…

PODD 0.0% todayRead at source ↗
● Business WireSep 18, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at Bernstein Insi…

PODD 0.0% todayRead at source ↗
● Business WireAug 31, 2026 · 14:22 ET
PODD DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026

NEW YORK--(BUSINESS WIRE)---- $PODD #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) an…

PODD 0.0% todayRead at source ↗
● Newsfile CorpAug 31, 2026 · 14:05 ET
PODD DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important August 31 Deadline in Securities Class Action - PODD

New York, New York--(Newsfile Corp. - August 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26…

PODD 0.0% todayRead at source ↗
● GlobeNewsWireAug 31, 2026 · 12:00 ET
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ: …

PODD 0.0% todayRead at source ↗
Business Wire · Nov 4, 2026

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA36−0.4%
INTC4−0.5%
LAW4−8.6%
ABR3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just PODD · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.